UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

Atherosclerosis, 2010-03, Vol.209 (1), p.173-177

2010

Volltextzugriff (PDF)

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)

Atherosclerosis, 2009-01, Vol.202 (1), p.272-281

2009

Volltextzugriff (PDF)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study

Atherosclerosis, 2010-08, Vol.211 (2), p.618-623

2010

Volltextzugriff (PDF)

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study

Atherosclerosis, 2003-09, Vol.170 (1), p.73-78

2003

Volltextzugriff (PDF)

ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN TREATED PATIENTS WITH SEVERE HYPERTRIGLYCERIDAEMIA: A LONG-TERM PROSPECTIVE REGISTRY STUDY

Atherosclerosis, 2009, Vol.207 (1), p.308-309

2009

Volltextzugriff (PDF)

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Diabetologia, 2015-07, Vol.58 (7), p.1494-1502

2015

Volltextzugriff (PDF)

Urinary 8-epi-PGF2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Biochemical and biophysical research communications, 2005-05, Vol.330 (3), p.731-736

2005

Volltextzugriff (PDF)

Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

FEBS letters, 1995-07, Vol.368 (2), p.225-229

1995

Volltextzugriff (PDF)

How to manage risk of macrovascular disease in patients with type II diabetes

Atherosclerosis, 2000-07, Vol.151 (1), p.245-245

Betteridge, D.J.

2000

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003-04, Vol.167 (2), p.243-255

2003

Volltextzugriff (PDF)

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study

Atherosclerosis, 2005-04, Vol.179 (2), p.293-297

2005

Volltextzugriff (PDF)

Editorial

European heart journal supplements, 2004-12, Vol.6 (suppl-G), p.G1-G2

2004

Volltextzugriff (PDF)

1.P.138 Cerivastatin - multicentre, double-blind comparison with placebo and simvastatin in primary hypercholesterolaemia

Atherosclerosis, 1997-10, Vol.134 (1-2), p.45-46

Betteridge, D.J.

1997

Volltextzugriff (PDF)

Measures of oxidative stress in heterozygous familial hypercholesterolaemia

Atherosclerosis, 2001-06, Vol.156 (2), p.435-441

2001

Volltextzugriff (PDF)

Urinary 8-epi-PGF{sub 2{alpha}} and its endogenous {beta}-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Biochemical and biophysical research communications, 2005-05, Vol.330 (3)

2005

Volltextzugriff (PDF)

Urinary 8-epi-PGF 2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Biochemical and biophysical research communications, 2005, Vol.330 (3), p.731-736

2005

Volltextzugriff (PDF)

Influence of the alpha-adrenoreceptor naftopidil and doxazosin, on adrenaline-induced serotonin platelets: comparison with the antagonists, collagen and efflux by human effects of nifedipine

Platelets (Edinburgh), 1997, Vol.8 (1), p.31-36

Alarayyed, B.N.C. Prichard, D.J. Betteridge, C.C.T. Smith, N.A.

1997

Volltextzugriff (PDF)

Diabetes, coronary heart disease and sulphonylureas—not the final word

European heart journal, 2000-05, Vol.21 (10), p.790-792

2000

Volltextzugriff (PDF)

Tu-S10:1 Summary of recent trials in secondary prevention and the high risk patient

Atherosclerosis. Supplements, 2006, Vol.7 (3), p.182-182

Betteridge, D.J.

2006

Volltextzugriff (PDF)

3.P.83 Plasma hydroperoxide levels are elevated in hypercholesterolaemic subjects with vascular complications

Atherosclerosis, 1997-10, Vol.134 (1-2), p.216-216

1997

Volltextzugriff (PDF)

Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care

International journal of clinical practice (Esher), 2004-02, Vol.58 (2), p.153-168

2004

Volltextzugriff (PDF)

Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care: MANAGEMENT OF SECONDARY PROPHYLAXIS IN PRIMARY CARE

International journal of clinical practice (Esher), 2004-02, Vol.58 (2), p.153-168

2004

Volltextzugriff (PDF)

Reduced platelet serotonin content and release in familial hypercholesterolaemia

Atherosclerosis, 1997-04, Vol.130 (1), p.87-92

1997

Volltextzugriff (PDF)

The effect of atorvastatin on serum lipide, lipoproteins and NMR-spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Atherosclerosis, 2003, Vol.167 (2)

2003

Volltextzugriff (PDF)

Introduction

International journal of cardiology, 1992-10, Vol.37, p.S1-S2

1992

Volltextzugriff (PDF)

1 – 25 von 91

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(70)
Mit Volltextzugriff
(74)

Publikationsform

Artikel
(91)

Sprache

Englisch
(89)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Effects of atorvastatin on serum soluble receptors for advanced glycation end-products in type 2 diabetes

Impact of peripheral arterial disease in patients with diabetes—Results from PROactive (PROactive 11)

All-cause and cardiovascular mortality in treated patients with severe hypertriglyceridaemia: A long-term prospective registry study

Comparison of the risk of fatal coronary heart disease in treated xanthomatous and non-xanthomatous heterozygous familial hypercholesterolaemia: a prospective registry study

ALL-CAUSE AND CARDIOVASCULAR MORTALITY IN TREATED PATIENTS WITH SEVERE HYPERTRIGLYCERIDAEMIA: A LONG-TERM PROSPECTIVE REGISTRY STUDY

Effect of atorvastatin on C-reactive protein and benefits for cardiovascular disease in patients with type 2 diabetes: analyses from the Collaborative Atorvastatin Diabetes Trial

Urinary 8-epi-PGF2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Plasma 8‐epi‐PGF2α levels are elevated in individuals with non‐insulin dependent diabetes mellitus

How to manage risk of macrovascular disease in patients with type II diabetes

The effect of atorvastatin on serum lipids, lipoproteins and NMR spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Non-coronary heart disease mortality and risk of fatal cancer in patients with treated heterozygous familial hypercholesterolaemia: a prospective registry study

Editorial

1.P.138 Cerivastatin - multicentre, double-blind comparison with placebo and simvastatin in primary hypercholesterolaemia

Measures of oxidative stress in heterozygous familial hypercholesterolaemia

Urinary 8-epi-PGF{sub 2{alpha}} and its endogenous {beta}-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Urinary 8-epi-PGF 2α and its endogenous β-oxidation products (2,3-dinor and 2,3-dinor-5,6-dihydro) as biomarkers of total body oxidative stress

Influence of the alpha-adrenoreceptor naftopidil and doxazosin, on adrenaline-induced serotonin platelets: comparison with the antagonists, collagen and efflux by human effects of nifedipine

Diabetes, coronary heart disease and sulphonylureas—not the final word

Tu-S10:1 Summary of recent trials in secondary prevention and the high risk patient

3.P.83 Plasma hydroperoxide levels are elevated in hypercholesterolaemic subjects with vascular complications

Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care

Guidelines on the management of secondary prophylaxis of vascular events in stable patients in primary care: MANAGEMENT OF SECONDARY PROPHYLAXIS IN PRIMARY CARE

Reduced platelet serotonin content and release in familial hypercholesterolaemia

The effect of atorvastatin on serum lipide, lipoproteins and NMR-spectroscopy defined lipoprotein subclasses in type 2 diabetic patients with ischaemic heart disease

Introduction

Suchergebnisse filtern